Thursday, 23 July 2020

Artificial kidney Market Shares Analysis, Key Development Strategies and Forecasts Till 2025

Market Analysis 
The global artificial kidney market is predicted to touch USD 2,795.01 million at a 6.9% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. An artificial kidney, simply put, is a portable medical device that allows people in experiencing the assistance of a dialysis anytime and anywhere. It is of two types- wearable artificial kidney and implantable artificial kidney. These devices are lightweight, which depend on highly permeable membranes, new filtering materials, advances in miniaturization, and long-lasting batteries. The month of March is declared as the National Kidney Month by the National Institutes of Health to increase awareness about chronic kidney diseases. 
Various factors are adding to the artificial kidney market growth. These factors, as per the new MRFR report, include growing geriatric population, increasing life expectancy, increasing disposable income, and developments in science and technology. Additional factors adding market growth include awareness campaigns, increasing cases of kidney diseases among Americans owing to surging rates of high blood pressure and diabetes, changing lifestyle, increasing awareness about renal failure diseases, low availability of kidney donors, and increasing R&D for improved dialysis process. 
On the contrary, engineering issues related to devices and problem with the artificial kidney size are factors that may limit the artificial kidney market growth over the forecast period. 
Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the global artificial kidney Market Growth based on dialysis and type. 
By type, the artificial kidney market is segmented into the implantable artificial kidney and wearable artificial kidney. Of these, the wearable artificial kidney segment will lead the market over the forecast period for the technical benefits of artificial organs and rising cases of renal failure. 
By dialysis, the artificial kidney market is segmented into peritoneal dialysis, hemodialysis, and combination. Of these, hemodialysis will dominate the market over the forecast period for the increasing number of hemodialysis procedures. 
Regional Analysis
Based on region, the global artificial kidney market report covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market over the forecast period. Factors propelling the global artificial kidney market in the region include increasing prevalence of chronic kidney diseases, increasing R&D by public and private organizations, and the presence of key players. 
The global artificial kidney market in Europe is predicted to hold the second-largest share over the forecast period for the growing geriatric population and increasing technological advances in technology and medicine. 
The global artificial kidney market in the Asia Pacific region is predicted to grow at a fast pace over the forecast period. Factors propelling the global artificial kidney market in the region include increasing prevalence of kidney diseases, increasing opportunities for key players for investing in the region, rising investments by government bodies, rising disposable income, and increasing prevalence of renal failure. 
The global artificial kidney market in the Middle East and Africa is predicted to have the lowest share over the forecast period for increasing awareness among patients regarding the different benefits of artificial kidney coupled with untapped markets. 
Key Players
Eminent players profiled in the global artificial kidney market report include Asahi Kasei Medical Vo., Ltd, Triomed AB. (Sweden), AWAK Technologies Pte.Ltd (Singapore), Blood Purification Technologies Inc., and Kawasumi Laboratories, Inc (Japan). Industry players have used strategies such as mergers and acquisitions, new product launch, joint ventures, contracts, extensive R&D, partnerships, strategic alliances, collaborations, and others to create a niche in the market as well as cater to the burgeoning needs of the customers. 


Read More Report :

Coronary Angiography Devices Market research Report – Forecast to 2023: https://www.marketresearchfuture.com/reports/coronary-angiography-devices-market-6151 

Global AI in Drug Discovery Market Research Report—Forecast till 2025 : https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393 
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312

Posted by at No comments:
Labels: ,

Neurovascular Devices Market -Trends, Analysis and Demand by 2023

Neurovascular Devices Market Synopsis:
Increased incorporation of advanced technology in the healthcare sector has led to the development of various medical devices that can be utilized to treat complex medical conditions. Neurovascular devices are advanced medical devices that are used to treat various neurovascular diseases that can affect the central nervous system and associated vascular system. Market Research Future (MRFR) has published a report stating that the global neurovascular devices market is marked to expand at a noteworthy CAGR of 8.8% during the forecast period of 2017-2023.


High prevalence of neurovascular diseases in developed and developing regions as a result of changing lifestyle and increased healthcare expenditure are majorly fueling the expansion of the global neurovascular devices market during the assessment period. Increased research and development expenditure and rapid technological advancement in the healthcare sector are also propelling the expansion of the global neurovascular devices market. However, poor economic conditions and lack of primary healthcare facilities are likely to restrain the expansion of the global neurovascular devices market during the forecast period. 

Neurovascular Devices Market Segmentation:
The global market for neurovascular devices has been segmented on the basis of product, therapeutic application, and end-user. Based on product, the neurovascular devices market has been segmented into aneurysm coiling and embolization devices, neurothrombectomy devices, support device, and cerebral balloon angioplasty and stenting systems. The aneurysm coiling and embolization devices segment has been sub-segmented into embolic coils, flow diversion devices, and liquid embolic. The embolic coils sub-segment includes detachable coils and pushable coils. The neurothrombectomy devices segment has been sub-segmented into retrieval systems and suction & aspiration devices. The support device segment has been sub-segmented into microguidewires and microcatheters. The cerebral balloon angioplasty & stenting systems segment has been sub-segmented into embolic protection systems and carotid artery stents. The embolic protection systems segmented is further segmented into balloon occlusion devices and distal filter devices. Based on therapeutic application, the neurovascular devices market has been segmented into hemorrhagic stroke and ischemic strokes. Based on end-users, the neurovascular devices market has been segmented into hospitals & clinics, and ambulatory surgical units.

Neurovascular Devices Market Regional Analysis:
Geographically, the global neurovascular devices market has been segmented into four major regions such as Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is dominating the global neurovascular devices market owing to the high prevalence of neurovascular diseases, increased healthcare expenditure as a result of increased disposable income, easy adoption of technologically advanced medical devices and the presence of well-developed healthcare sector in this region. The Europe region commands second largest share in the global neurovascular devices market owing to the rapid technological advancement and increased research and development activities for the introduction of advanced medical devices in the developed healthcare sector of this region. The neurovascular devices market in the Asia Pacific region is expanding at the fastest growth rate owing to the increased awareness regarding the availability of advanced medical devices and increased government funding for the development of healthcare sector in this region. Whereas, poor economic condition and absence of primary healthcare facilities in the underdeveloped countries are restraining the growth of the neurovascular devices market in the Middle East and Africa region.     

 Neurovascular Devices Market Top Key Players:
The key players profiled by MRFR that are operating in the global neurosurgery devices market are Stryker, Medtronic, Johnson & Johnson Services, Inc., TERUMO CORPORATION, Abbott, Merit Medical Systems, Inc., Medikit co., ltd., Penumbra, Inc., MicroPort Scientific Corporation, Evasc, Rapid Medical, Neuravi, W. L. Gore & Associates, Inc., OxfordEndovascular, Sensome, Blockade Medical, LLC., Delaware Corporation, Secant Group, LLC, and Gynesonics. The players in the global neurovascular devices market are aiming towards expansion of their businesses on global level by introducing advanced devices through increased research and development expenditure and strategic mergers and acquisitions are aiding these players in maintaining their dominance in the highly competitive environment of the global neurovascular devices market.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Posted by at No comments:
Labels: ,

Cardiovascular Application Market 2020- Trends, Demand, Research by Analysis

Cardiovascular applications include devices and equipment used in diagnosing, monitoring, and treatment of cardiovascular diseases. The increasing number of patients diagnosed with cardiovascular diseases is a definite growth enabler of these devices. The global cardiovascular application market report by Market Research Future (MRFR) highlights several trends and opportunities for end-users for the period of 2018 to 2023 (forecast period).
Market Scope
The global cardiovascular application market Growth size can touch a value of USD 36,730.5 million by 2023. It can display a CAGR of 7.24% over the forecast period. Rising prevalence of cardiovascular diseases, the large vulnerable geriatric populace, and reimbursement policies are major drivers of the market. According to the World Health Organization (WHO), close to 17.7 million patients have died from cardiovascular diseases (CVDs). This can culminate in a spike in the demand for cardiovascular devices. Rise in cases of obesity can also act as a precursor to CVDs and spur market demand. 
Government efforts to reduce hospital acquired infections (HAIs) is expected to fuel market demand exponentially. It can result in the demand for diagnostic and monitoring devices. Adoption of remote patient monitoring and home healthcare are likely to spike the demand in home care centers and home settings. Rapid urbanization has led to the migration of various patients to cities, whose sedentary lifestyle has contributed to CVDs. Diagnostic devices and monitoring devices can make up for maximum sales of the cardiovascular application market owing to the need for devices for rapid diagnosis of diseases at an early stage.
However, strict regulations pertaining to their approval can impede market growth.
Segmentation
The global cardiovascular application market has been segmented into device, end user, and region. By device, the market has been segmented into cardiac monitors, cardiac pacemakers, and cardiac defibrillators. Cardiac monitors accounted for a market value of USD 6131.7 million in 2018.
Based on end user, the market has been divided into hospitals, cardiac care centers, ambulatory centers & home care, and academic centers. 
Regional Analysis
The global cardiovascular application market covers the regions of the Europe, Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas accounted for a major market share owing to high healthcare spending, large number of cases of CVDs, and well-developed technology. The strong economic growth of the U.S. and Canada as well as the breakthroughs in medical devices can fuel the regional cardiovascular devices market. Adoption of home healthcare devices and rise of telemedicine are drivers of the market.  
Europe accounted for the second-largest market share owing to a well-developed economy, healthcare budget, and increasing number of cases of obesity and diabetes. According to the World Health Organization (WHO), CVDs accounted for 46 times the mortality rates of citizens in comparison to tuberculosis, malaria, and AIDS. Digital platform which encourage home monitoring of patients with CVDs can bode well for the market.
APAC can exhibit the fastest growth rate during the forecast period owing to a large patient pool, improving technology, and need for advanced diagnostic devices. The geriatric population as well as allocation of funds in the corpus of healthcare budget of countries is factors which can influence the market. Rise in medical tourism as well as affordable surgeries and procedures conducted at affordable rates can drive the demand for these devices. Initiatives to modernize healthcare infrastructure and demand for advanced healthcare facilities are other drivers of the market.
Competitive Outlook
Koninklijke Philips NV, GENERAL ELECTRIC, Boston Scientific Corporation, Abbott, Stryker, Terumo Corporation, and Medtronic are major players of the global cardiovascular application market. Acquisitions, novel product launches, and innovational breakthroughs are strategies being implemented by players to gain the edge in the market.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details
Posted by at No comments:
Labels: ,

Wednesday, 1 July 2020

Covid19 Impact on Head Trauma Market : Global Trends, Analysis and Forecast

Market Highlights
Over the last decade, the number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.
According to the National Safety Council reports, head trauma caused estimated 4.6 million accident related injuries and 40,200 deaths in 2016 worldwide. Moreover, average car accident data from 2005-2015, it is estimated that 5,808,272 car accidents occur every year in the U.S.
Increasing prevalence of neurological/brain disorder like epilepsy, rising need for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds drive the growth of the market. Furthermore, increasing government support for research & development, changing lifestyle, and rapid development in technology are likely to fuel the market growth during the forecast period. On the other hand, higher cost of the treatment procedure may slow the market growth during the review period.
The Global Head Trauma Market is expected to grow at a CAGR of ~8.3% during the forecast period 2017-2023.
Regional Analysis
The Americas dominate the global head trauma market owing to the presence of huge patient population, high health care spending, and increasing government support for research & development. Moreover presence of major market players may boost the market growth during the forecast period.      
Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating various brain disorders or brain injuries such as epilepsy, and depression are likely to have a positive impact on the growth of the market. The growing public awareness may boost the adoption of these devices in the European market.
Asia Pacific is the fastest growing head trauma market across the globe. Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.       
The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.  
Segmentation
The global head trauma market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of the type, it is segmented into hematoma, and hemorrhage. On the basis of the diagnosis, it is segmented into physical examination, blood test, brain scans, and others. The brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG). Based on the treatment it is segmented into medical treatment, anti-seizure drugs, surgery, and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories, and others.
Key Players
Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Monday, 29 June 2020

Intravenous Solutions Market- Trends, Analysis, Global Growth and Forecast to 2023

Global Intravenous (IV) Solution Market: Information by Types (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral lipid Emulsion and other Solutions), End Users (Hospital & Clinics, Ambulatory and Home Care) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2022
Market Synopsis:
The advancements in the healthcare sector are inducing growth in the markets that offer medical products. Intravenous systems form a crucial part of medical treatments and surgeries. It is expected to witness high demand over the next couple of years. A study, offered by Market Research Future (MRFR), has found out that the global Intravenous (IV) Solution market is expected to register a CAGR of 7.69% across the projection period 2016 to 2022. The assessment also asserts that the market is anticipated to scale a valuation of USD 11,511.2 Mn by the end of 2022. 
IV solutions are extensively used for treatments ranging from fluid deficiency to cancer diagnosis. The rising burden of chronic diseases is likely to propel the expansion of Intravenous Solutions Market growth in the years to come. The demand for IV solution is huge and signifies opportunities for innovations. Many companies are leveraging packaged intravenous fluids with sterile water for administration to patients. It has already garnered a considerable share of the Intravenous (IV) Solution market and is likely to witness an upswing in demand in the foreseeable future.
The healthcare sector is observing a boom and is expected to thrive further over the assessment period. This, in turn, is anticipated to propel the expansion of the Intravenous (IV) Solution market in the upcoming years. In addition, it has been projected that the rising adoption of vitamin C intravenous treatment therapy for the treatment of colorectal cancer will unleash developmental opportunities for the market players. 
Market Segmentation:
By type, the global Intravenous (IV) Solution market has been bifurcated into total parenteral solution, peripheral parenteral solution. Among these, the total parenteral solution segment was valued at USD 4,940.0 Mn in 2016 and is expected to hold the dominant share of the market over the assessment period. 
Based on nutritional content, the Intravenous (IV) solution market has been segmented into carbohydrates, amino acid solution, vitamins & minerals, parenteral lipid emulsion, and others. The amino acid solution segment, which stood at a valuation of USD 2,385 Mn in 2016, is expected to retain its pole position through the review period.
By end user, the global Intravenous (IV) solution market has been segmented into hospitals & clinics, ambulatory, and home care.
Regional Analysis:
The global Intravenous (IV) solution market, by region, has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). North America held the leading position in the global marketplace in 2015. It is forecasted to retain its forefront position over the review period. The rising prevalence of cancer in conjunction with high consumption of IV solution is poised to fuel the growth of the Intravenous (IV) Solution market in the forthcoming years. 
Asia Pacific is expected to scale the highest CAGR of 8.34% between 2016 and 2022. The developments in the healthcare sector of the region backed by increasing healthcare expenditure are anticipated to augment the Intravenous (IV) solution market over the next couple of years. 
Competitive Dashboard:
The key players of the Intravenous (IV) Solution market profiled in this MRFR report are ICU Medical, Inc. (U.S.), Fresenius Kabi AG (Germany), B. Braun Melsungen AG (Germany), Baxter (U.S.), Terumo Medical Corporation (Tokyo), Amanta Healthcare (India), and Grifols S.A. (Spain).
Industry News:
In May 2019, B. Braun Medical, a German medical and pharmaceutical device company, has announced its investment of USD 1 Bn in into new and existing IV fluid manufacturing facilities for alleviating he IV solution shortage.
In May 2019, Phebra, an Australian pharmaceutical firm, has initiated its international business expansion with the inauguration of its subsidiary entity in Canada, namely Phebra Canada.
Read more @ https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Posted by at No comments:
Labels: , ,

Ligation Devices Market Size, Regional Outlook, Competitive Strategies and Forecasts, 2018 to 2023

Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024
Market research future will be publishing a Half cooked research report on “Global ligation devices industry trends” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 
Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.
Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.
Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.
Regional Analysis
The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.
In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.
On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/ligation-devices-market-7794
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Retinal vein occlusion treatment market size share global industry research key companies review forecast to 2023

Market Highlights
Glaucoma is a condition where the eye pressure causes damage to the optic nerve. The increasing number of patients with glaucoma is leading the retinal vein occlusion market offering a huge growth opportunity to the market players. Moreover, the growing number of patients affected with lymphoma and multiple myeloma is also fueling the growth of the global retinal vein occlusion market.
According to the Centers for Disease Control and Prevention, in 2014, around 47,135 people were diagnosed with leukemia and out of which 23,564 people died from the disease. According to the American Cancer Society, around 4% of all cancers in the United States is lymphoma, additionally, it is estimated that in 2018, about 74,680 people including both adults and children will be diagnosed with lymphoma and around 19,910 people will die from this. According to the American Cancer Society, the risk of acquiring multiple myeloma in the United States is 1 in 143 that is 0.7%, additionally, it is estimated that in 2018, around 30,770 new cases are likely to be diagnosed and the estimated death toll would be around 12,770.
The global retinal vein occlusion treatment market is expected to grow at a CAGR of 11.2% during the forecast period 2017-2023.
Taste the market data and market information presented through more than 150 market data tables and figures spread over 206 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “retinal vein occlusion market research report–Global forecast till 2023.”
Major Players in the Retinal Vein Occlusion Market
Some of the key players in this market are Allergan, Bayer, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Ellex Medical Lasers, GlaxoSmithKline Plc, IRIDEX Corporation, Novartis, Quantel Medical Inc, Topcon Medical Systems, Inc., ZEISS, Lumenis, Sanofi Aventis, Valeant Pharmaceuticals, Alimera Sciences, Fovea Pharmaceuticals SA, Icon Biosciences, Suzuken Co.Ltd, Genentech, Inc.,  Ranbaxy Pharmaceuticals, Johnson & Johnson Services, Inc, Teva Pharmaceutical, Pfizer Inc., Astrazeneca, Aerpio Therapeutics Inc, Annexin Pharmaceuticals AB  and others.
The global retinal vein occlusion market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of eye diseases. Additionally, high healthcare spending, well-developed technology, and increasing geriatric population will fuel the growth of the market.  
The Americas market for retinal vein occlusion is divided into North America and South America. North America holds the major share in the market whereas, South America is showing the fastest growth owing to the presence of a huge opportunity for the development of the market in the region.
The Europe retinal vein occlusion market comprises of Eastern Europe and Western Europe. Western Europe comprises of countries such as Germany, the U.K, France, Italy, and Spain. Europe accounts for the second largest market for the global retinal vein occlusion owing to increasing support from the government, the presence of huge geriatric population, and high healthcare spending. Also, many European countries are trying to encourage the manufacturers for research & development for the introduction of advanced devices. In addition to this, increasing awareness and development in the healthcare infrastructure has provided a push to the growth of the market.
Asia Pacific is the fastest growing market for the global retinal vascular or vein occlusion. Presence of huge patient population, rapid development in technology and presence of a huge opportunity for the development of the market drives the growth of Asia Pacific retinal vascular or vein occlusion market. Also, the government of this region is looking forward to avail better treatment options from developed nations in order to improve the quality of life of their citizens. Additionally, growing geriatric population is also fueling the growth of the market in this region.
On the other hand, the Middle East & Africa holds the least share but will be a fastest growing region in the forecast period. However, due to the presence of poor and slow developing countries, especially, in the African region, it may hold least market share.
Segmentation
The global retinal vein occlusion market is segmented on the basis of type, condition, diagnosis, treatment, and end user. On the basis of the type, it is segmented into branch retinal artery occlusion and central retinal vein occlusion. On the basis of the condition, it is segmented into non-ischemic and ischemic. Based on the diagnosis, it is segmented into optical coherence tomography (OCT), fundoscopic examination, fluorescein angiography, and others. On the basis of treatment, it is segmented into antivascular endothelial growth factor, corticosteroid drugs, laser retinal photocoagulation, and others. On the basis of the end users, it is segmented into hospitals and clinics, research & academics centers, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)